BioSpace News Archive

Pharm Country

Journal for ImmunoTherapy of Cancer Highlights New Single Cell Bioinformatics Tools From IsoPlexis Used To Characterize Differences in CAR-T Products

These new tools enable researchers to better compare key differences between products, and more easily analyze highly-multiplexed, single CAR-T cell functional profiles to gain insight into CAR-T product potency and cytokine mediated immuno-toxicity.

November 21, 2017

·

3 min read

Business

Mitsubishi Tanabe Pharma America Expands Executive Leadership Team, Names Kevin O’Brien as Vice President of Market Access

O’Brien will oversee the development of U.S. market access strategy and implementation, as well as payer contracting and reimbursement initiatives, to enable patient access to RADICAVA and future pipeline products.

November 21, 2017

·

2 min read

MiMedx Provides Update on its Reimbursement Coverage

MiMedx provided a reimbursement update today.

November 21, 2017

·

6 min read

Drug Development

Nevakar Announces First Subject Dosed in its Phase III Clinical Trial of NVK-002 for the Treatment of Myopia in Children

If successful in Phase III and then in obtaining approval from the FDA, NVK-002 would represent the first pharmacologic eye drop for this patient population.

November 21, 2017

·

4 min read

BioCapital

Statement From FDA Commissioner Scott Gottlieb, M.D., on Steps to Promote Development of Generic Versions of Opioids Formulated to Deter Abuse

As we continue to confront the staggering human and economic toll created by opioid abuse and addiction, we’re focused on taking actions that reduce the scope of new addiction by decreasing unnecessary exposure to opioids.

November 21, 2017

·

6 min read

Deals

Alpha Source Closes Bc Technical Business Deal Creating One of The Largest Independent Imaging and Medical Equipment Service Companies in the U.S.

The acquisition doubles the size of Alpha Source and creates one of the largest independent full service, imaging services and equipment repair solutions companies in the U.S.

November 21, 2017

·

4 min read

Business

Lead Pharma Achieves Third Milestone in Sanofi Collaboration for Development of Autoimmune Diseases Treatments

The collaboration aims to develop small molecules directed against the nuclear hormone receptor ROR gamma (t) for the treatment of a broad range of autoimmune disorders, including common diseases such as psoriasis, rheumatoid arthritis and inflammatory bowel disease.

November 21, 2017

·

1 min read

Genetown

Oxford Immunotec to Present at the 29th Annual Piper Jaffray Healthcare Conference

A live webcast of the presentation will be available online from the investor relations page of the Company’s corporate website at www.oxfordimmunotec.com.

November 21, 2017

·

1 min read

Drug Development

Janssen Submits Application to U.S. FDA to Expand Indication for DARZALEX (daratumumab) Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma who are Transplant Ineligible

Janssen Biotech today announced that it has submitted a supplemental sBLA to the FDA for DARZALEX (daratumumab).

November 21, 2017

·

17 min read

Biotech Beach

Avelas Biosciences to Present at Piper Jaffray Healthcare Conference

Avelas BioSciences today announced that Carmine N. Stengone, president and CEO, will present at the 29th Annual Piper Jaffray Healthcare Conference on Tuesday, November 28, 2017, at 4:50 p.m. EST in New York City.

November 21, 2017

·

1 min read